4. Avandia - Top 10 Warnings and Recalls

Drug: Avandia

2006 sales: $3.4 billion

Manufacturer: GlaxoSmithKline

Safety concern: “black box;” heart failure, heart attack

Related Articles:
> New Avandia warning 'a muddle'. Report
> Avandia warning, comeback imminent? Report
> Avandia cleared FDA by one vote. Report
> Avandia, Actos don't boost death risk. Report
> FDA adds to drumbeat of bad news for Avandia. Report
> Expert committee says Avandia should stay. Report
> FDA expert wants Avandia withdrawn. Report
> Docs shunning Avandia in wake of safety study. Report
> Avandia risks exposed under deal to post data. Report

4. Avandia - Top 10 Warnings and Recalls
Read more on

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.